Inhibition of STAT3 by Niclosamide Synergizes with Erlotinib against Head and Neck Cancer

Rui Li; Shuo You; Zhongliang Hu; Zhuo G. Chen; Gabriel L. Sica; Fadlo R. Khuri; Walter J. Curran; Dong M. Shin; Xingming Deng

doi:10.1371/journal.pone.0074670

Loading metrics

Open Access

Peer-reviewed

Research Article

Inhibition of STAT3 by Niclosamide Synergizes with Erlotinib against Head and Neck Cancer

Rui Li,

Affiliation Department of Radiation Oncology, Emory University School of Medicine and Winship Cancer Institute, Emory University, Atlanta, Georgia, United States of America
⨯
Shuo You,

Affiliation Department of Radiation Oncology, Emory University School of Medicine and Winship Cancer Institute, Emory University, Atlanta, Georgia, United States of America
⨯
Zhongliang Hu,

Affiliation Department of Hematology and Medical Oncology, Emory University School of Medicine and Winship Cancer Institute, Emory University, Atlanta, Georgia, United States of America
⨯
Zhuo G. Chen,

Affiliation Department of Hematology and Medical Oncology, Emory University School of Medicine and Winship Cancer Institute, Emory University, Atlanta, Georgia, United States of America
⨯
Gabriel L. Sica,

Affiliation Department of Pathology, Emory University School of Medicine and Winship Cancer Institute, Emory University, Atlanta, Georgia, United States of America
⨯
Fadlo R. Khuri,

Affiliation Department of Hematology and Medical Oncology, Emory University School of Medicine and Winship Cancer Institute, Emory University, Atlanta, Georgia, United States of America
⨯
Walter J. Curran,

Affiliation Department of Radiation Oncology, Emory University School of Medicine and Winship Cancer Institute, Emory University, Atlanta, Georgia, United States of America
⨯
Dong M. Shin,

Affiliation Department of Hematology and Medical Oncology, Emory University School of Medicine and Winship Cancer Institute, Emory University, Atlanta, Georgia, United States of America
⨯
Xingming Deng

* E-mail: xdeng4@emory.edu

Affiliation Department of Radiation Oncology, Emory University School of Medicine and Winship Cancer Institute, Emory University, Atlanta, Georgia, United States of America
⨯

Inhibition of STAT3 by Niclosamide Synergizes with Erlotinib against Head and Neck Cancer

Rui Li,
Shuo You,
Zhongliang Hu,
Zhuo G. Chen,
Gabriel L. Sica,
Fadlo R. Khuri,
Walter J. Curran,
Dong M. Shin,
Xingming Deng

Published: September 3, 2013
https://doi.org/10.1371/journal.pone.0074670

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Head and neck cancers
Is the Subject Area "Head and neck cancers" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Phosphorylation
Is the Subject Area "Phosphorylation" applicable to this article?

Thanks for your feedback.
Lung and intrathoracic tumors
Is the Subject Area "Lung and intrathoracic tumors" applicable to this article?

Thanks for your feedback.
Gastrointestinal cancers
Is the Subject Area "Gastrointestinal cancers" applicable to this article?

Thanks for your feedback.
Renal cancer
Is the Subject Area "Renal cancer" applicable to this article?

Thanks for your feedback.
Phosphatases
Is the Subject Area "Phosphatases" applicable to this article?

Thanks for your feedback.
Quantum dots
Is the Subject Area "Quantum dots" applicable to this article?

Thanks for your feedback.